SCHEMBL8001935

SCHEMBL8001935

COc1ccc(Sc2c(-c3ccc(-c4nnco4)cc3)nc(-c3ccccn3)n2C)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.47
EDNRA P25101 1/20 0.38
ATR Q13535 1/20 0.34
KDM4E B2RXH2 3/20 0.34
RXFP1 Q9HBX9 1/20 0.34
L3MBTL1 Q9Y468 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
PKM P14618 2/20 0.33
HSP90AA1 P07900 1/20 0.33
NOTUM Q6P988 3/20 0.33
ALDH1A1 P00352 7/20 0.32
MAPT P10636 3/20 0.32
HTT P42858 3/20 0.32
GAA P10253 2/20 0.32
PPP1CA P62136 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
TLR8 Q9NR97 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12106423 0.89 FAAH (0.49) FAAHEDNRAKDM4ERXFP1NPC1
SCHEMBL8005530 0.89 FAAH (0.49) FAAHEDNRAL3MBTL1NPC1RAB9A
SCHEMBL8001993 0.86 FAAH (0.52) FAAHEDNRAKDM4ERXFP1L3MBTL1
SCHEMBL8004010 0.85 FAAH (0.61) FAAHEDNRAKDM4ERXFP1L3MBTL1
SCHEMBL8011114 0.85 FAAH (0.50) FAAHKDM4ERXFP1L3MBTL1NPC1
SCHEMBL8002857 0.82 FAAH (0.48) FAAHEDNRAKDM4ERXFP1NPC1
SCHEMBL12106397 0.80 FAAH (0.43) FAAHEDNRAKDM4ERXFP1L3MBTL1
SCHEMBL1303819 0.79 FAAH (0.50) FAAHEDNRAKDM4ERXFP1L3MBTL1
SCHEMBL8001939 0.78 FAAH (0.42) FAAHEDNRAKDM4ERXFP1NPC1
SCHEMBL8001937 0.78 FAAH (0.41) FAAHEDNRAKDM4ERXFP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885EDNRA 2331/4885ATR 4098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.